|
PPP2R5A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.797270E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.373400E-04 |
| Normal-vs-Stage2 |
2.558800E-03 |
| Normal-vs-Stage3 |
1.571590E-04 |
| Normal-vs-Stage4 |
1.059170E-01 |
| Stage1-vs-Stage2 |
7.866200E-01 |
| Stage1-vs-Stage3 |
4.865400E-01 |
| Stage1-vs-Stage4 |
6.007400E-01 |
| Stage2-vs-Stage3 |
7.754000E-01 |
| Stage2-vs-Stage4 |
3.758200E-01 |
| Stage3-vs-Stage4 |
2.010200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.987400E-04 |
| Normal-vs-AfricanAmerican |
1.412750E-04 |
| Normal-vs-Asian |
3.414100E-02 |
| Caucasian-vs-AfricanAmerican |
6.202200E-01 |
| Caucasian-vs-Asian |
6.738400E-01 |
| AfricanAmerican-vs-Asian |
6.570800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.376680E-04 |
| Normal-vs-Female |
7.684000E-03 |
| Male-vs-Female |
3.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.664250E-01 |
| Normal-vs-Extreme_Weight |
1.777270E-03 |
| Normal-vs-Obese |
4.761700E-04 |
| Normal-vs-Extreme_Obese |
2.004200E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.566200E-01 |
| Normal_Weight-vs-Obese |
4.701600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.625900E-02 |
| Extreme_Weight-vs-Obese |
9.556200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.225400E-01 |
| Obese-vs-Extreme_Obese |
1.310380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.057840E-01 |
| Normal-vs-Age(41-60Yrs) |
1.064830E-03 |
| Normal-vs-Age(61-80Yrs) |
5.378300E-04 |
| Normal-vs-Age(81-100Yrs) |
7.54980000000627E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.679800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.955000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.263800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.563400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.752300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.199700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.237560E-03 |
| Normal-VS-Type2 PRCC |
5.377200E-04 |
| Normal-VS-KIRP CIMP |
4.231400E-01 |
| Normal-VS-Unclassified PRCC |
4.14880000000339E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.991840E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.554000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.060430E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.353000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.412200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.748500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.45020000452689E-08 |
| Normal-vs-N1 |
6.689500E-02 |
| Normal-vs-N2 |
1.190210E-01 |
| N0-vs-N1 |
1.604540E-03 |
| N0-vs-N2 |
3.110800E-01 |
| N1-vs-N2 |
5.743200E-01 |
|
|
